Innovative Assessment NeuroGeneces offers the NeuroInsight™ assessment that detects atypical brain decline decades before symptoms, presenting an opportunity to engage healthcare providers, clinics, and wellness centers focused on early intervention and preventative care.

Growing Market With a revenue range of 1 to 10 million and ongoing trials, the company is positioned in a rapidly expanding market for brain health and neurodegenerative disease prevention, suitable for partnerships with research institutions and biotech firms.

Technology Integration Utilizing platforms like Squarespace and Google Analytics, NeuroGeneces demonstrates a digital-first approach, making it easier to target and convert health-conscious consumers through effective online marketing and educational campaigns.

Funding & Resources With recent minimal funding of only 10K, there is potential for strategic investors or grants to accelerate R&D, clinical trials, and market entry, providing opportunities for collaborative growth and scaled outreach.

Collaborative Expansion The company can explore partnerships with larger neurotherapeutic and wellness firms, similar to industry peers, to leverage their networks, accelerate adoption, and expand into broader health markets targeting cognitive health.